Memed

BrazilHealthtech

Memed is a Brazilian healthtech company that provides a digital prescription platform for medical clinics. It leverages artificial intelligence to streamline the prescription process, helping healthcare professionals manage and issue digital drug prescriptions. The platform serves doctors and patients in Brazil, aiming to reduce errors and improve efficiency in clinical practice. Memed has raised significant funding, including an R$80 million round led by DGF and BridgeOne, and a ~USD20 million extension led by DNA Capital, Temasek, and Fit Participações, and has reportedly reached breakeven while targeting unicorn status.

Website